These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31255638)

  • 1. Foot Function Index: A Promising Questionnaire for Individuals With Charcot-Marie-Tooth Disease Type 1A.
    Bihel L; Reynaud V; Givron P; Clavelou P; Cornut-Chauvinc C; Pereira B; Thomas E; Taithe F; Coudeyre E
    Arch Phys Med Rehabil; 2019 Dec; 100(12):2403-2406. PubMed ID: 31255638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome measures in the clinical evaluation of ambulatory Charcot-Marie-Tooth 1A subjects.
    Mori L; Prada V; Signori A; Pareyson D; Piscosquito G; Padua L; Pazzaglia C; Fabrizi GM; Smania N; Picelli A; Schenone A;
    Eur J Phys Rehabil Med; 2019 Feb; 55(1):47-55. PubMed ID: 29898585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor performance deterioration accelerates after 50 years of age in Charcot-Marie-Tooth type 1A patients.
    Tozza S; Bruzzese D; Pisciotta C; Iodice R; Esposito M; Dubbioso R; Ruggiero L; Topa A; Spina E; Santoro L; Manganelli F
    Eur J Neurol; 2018 Feb; 25(2):301-306. PubMed ID: 29053907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with foot and ankle strength in healthy preschool-age children and age-matched cases of Charcot-Marie-Tooth disease type 1A.
    Rose KJ; Burns J; North KN
    J Child Neurol; 2010 Apr; 25(4):463-8. PubMed ID: 19671887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Afferent control of walking: are there distinct deficits associated to loss of fibres of different diameter?
    Nardone A; Corna S; Turcato AM; Schieppati M
    Clin Neurophysiol; 2014 Feb; 125(2):327-35. PubMed ID: 23948160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidimensional evaluation is necessary to assess hand function in patients with Charcot-Marie-Tooth disease type 1A.
    Reynaud V; Conforto I; Givron P; Clavelou P; Cornut-Chauvinc C; Taithe F; Pereira B; Coudeyre E
    Ann Phys Rehabil Med; 2021 Mar; 64(2):101362. PubMed ID: 32109594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Walking Speed Is Correlated With the Isokinetic Muscular Strength of the Knee in Patients With Charcot-Marie-Tooth Type 1A.
    Reynaud V; Morel C; Givron P; Clavelou P; Cornut-Chauvinc C; Pereira B; Taithe F; Coudeyre E
    Am J Phys Med Rehabil; 2019 May; 98(5):422-425. PubMed ID: 30365400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flexible cavovarus feet in Charcot-Marie-Tooth disease treated with first ray proximal dorsiflexion osteotomy combined with soft tissue surgery: a short-term to mid-term outcome study.
    Leeuwesteijn AE; de Visser E; Louwerens JW
    Foot Ankle Surg; 2010 Sep; 16(3):142-7. PubMed ID: 20655015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An anterior ankle-foot orthosis improves walking economy in Charcot-Marie-Tooth type 1A patients.
    Menotti F; Laudani L; Damiani A; Mignogna T; Macaluso A
    Prosthet Orthot Int; 2014 Oct; 38(5):387-92. PubMed ID: 24100074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessement of quadriceps strength, endurance and fatigue in FSHD and CMT: benefits and limits of femoral nerve magnetic stimulation.
    Bachasson D; Temesi J; Bankole C; Lagrange E; Boutte C; Millet GY; Verges S; Levy P; Feasson L; Wuyam B
    Clin Neurophysiol; 2014 Feb; 125(2):396-405. PubMed ID: 24001968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of functional surgery associated with early intensive rehabilitation therapy in Charcot-Marie-Tooth Type 1A disease.
    Ferraro F; Dusina B; Carantini I; Strambi R; Galante E; Gaiani L
    Eur J Phys Rehabil Med; 2017 Oct; 53(5):788-793. PubMed ID: 28264542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study.
    Verhamme C; van Schaik IN; Koelman JH; de Haan RJ; de Visser M
    Brain; 2009 Dec; 132(Pt 12):3252-62. PubMed ID: 19843647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rehabilitation interventions for foot drop in neuromuscular disease.
    Sackley C; Disler PB; Turner-Stokes L; Wade DT; Brittle N; Hoppitt T
    Cochrane Database Syst Rev; 2009 Jul; (3):CD003908. PubMed ID: 19588347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life in patients with Charcot-Marie-Tooth disease.
    Vinci P; Serrao M; Millul A; Deidda A; De Santis F; Capici S; Martini D; Pierelli F; Santilli V
    Neurology; 2005 Sep; 65(6):922-4. PubMed ID: 16186535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postural instability in Charcot-Marie-Tooth 1A disease.
    Tozza S; Aceto MG; Pisciotta C; Bruzzese D; Iodice R; Santoro L; Manganelli F
    Gait Posture; 2016 Sep; 49():353-357. PubMed ID: 27491052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in walking velocity and stride parameters with age in children with Charcot-Marie-Tooth disease.
    Õunpuu S; Pierz KA; Acsadi G; Wren TAL
    Neuromuscul Disord; 2020 Oct; 30(10):825-832. PubMed ID: 32928646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability and Validity of the Korean Version of the Foot Function Index.
    Huh JW; Eun IS; Ko YC; Park MJ; Hwang KM; Park SH; Park TH; Park JH
    J Foot Ankle Surg; 2016; 55(4):759-61. PubMed ID: 27067199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hand function in Charcot Marie Tooth: test retest reliability of some measurements.
    Svensson E; Häger-Ross C
    Clin Rehabil; 2006 Oct; 20(10):896-908. PubMed ID: 17008341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthopaedic shoes along with physical therapy was effective in Charcot-Marie-Tooth patient over 10 years.
    Bensoussan L; Jouvion A; Kerzoncuf M; Delarque A; Theodoridou E; Milhe de Bovis V; Thefenne L; Attarian S; Viton JM
    Prosthet Orthot Int; 2016 Oct; 40(5):636-42. PubMed ID: 26015326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between clinical/neurophysiological findings and quality of life in Charcot-Marie-Tooth type 1A.
    Padua L; Shy ME; Aprile I; Cavallaro T; Pareyson D; Quattrone A; Rizzuto N; Vita G; Tonali P; Schenone A
    J Peripher Nerv Syst; 2008 Mar; 13(1):64-70. PubMed ID: 18346232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.